Acute myeloid leukemia Press Release

Title Picture
07/11/2018 - 03:01
Genentech Announces Submission of Supplemental New Drug Application for Venclexta for People With Previously Untreated Acute Myeloid Leukemia who are Ineligible for Intensive Chemotherapy
Genentech's picture
Genentech
07/02/2018 - 02:35
Alexs Lemonade Stand Foundation Announces 2018 Epidemiology Grant Recipients
Alexs Lemonade's picture
Alexs Lemonade
06/27/2018 - 01:30
U.S. FDA Grants Priority Review for Pfizers New Drug Application for Glasdegib in Patients with Previously Untreated Acute Myeloid Leukemia
Pfizer's picture
Pfizer
06/18/2018 - 15:09
Data presented at EHA shows significantly improved overall survival compared to historical data
Biolinerx's picture
Biolinerx
06/09/2018 - 06:14
Patient Who Pioneered '7 + 3' Treatment at Roswell Park Celebrates 97th Birthday
Roswell Park Cancer Institute's picture
Roswell Park Ca...
05/31/2018 - 13:02
MEI Pharma and Helsinn Group Announce Successful Interim Analysis of Pracinostat/Azacitidine Phase 2 Combination Study in Higher Risk Myelodysplastic Syndrome (MDS) Patients
MEI Pharma's picture
MEI Pharma
05/22/2018 - 12:18
Approval of UCART123 Amendment in AML to Accelerate Clinical Development
Cellectis's picture
Cellectis
05/17/2018 - 13:00
BioLineRx to Present Overall Survival Data at EHA from Phase 2a Study of BL-8040 in r/r AML Patients
Biolinerx's picture
Biolinerx
05/16/2018 - 06:46
BioLineRx Announces Grant of European Patent Covering Use of BL-8040 with Cytarabine for Treating Acute Myeloid Leukemia
Biolinerx's picture
Biolinerx
04/23/2018 - 04:55
MYLOTARG Approved In The EU For The Treatment Of Previously Untreated, De Novo, CD33-positive Acute Myeloid Leukemia In Combination With Chemotherapy
Pfizer's picture
Pfizer
04/17/2018 - 04:55
Getting Personal with AML Treatment
Celgene's picture
Celgene
03/26/2018 - 14:17
Farewell to a Pioneer: Dr. James Holland Dared to Dream of Cures
Roswell Park Cancer Institute's picture
Roswell Park Ca...
02/23/2018 - 10:04
Pfizer Receives Positive CHMP Opinion for Two Hematology Medicines, MYLOTARG and BOSULIF
Pfizer's picture
Pfizer
02/15/2018 - 06:28
Successful NK cell-based immunotherapy for leukaemia
Karolinska Institutet's picture
KarolinskaInstitutet
01/11/2018 - 01:58
Helsinn Group and MEI Pharma Announce that Pracinostat has Received Orphan Drug Designation from the European Medicines Agency for the Treatment of Acute Myeloid Leukemia (AML)
MEI Pharma's picture
MEI Pharma
12/11/2017 - 15:37
Study identifies agent that can reverse resistance to targeted drug in some leukemia cell types
Dana Farber's picture
Dana Farber
12/11/2017 - 08:27
Roswell Park Hematology Experts Sharing New Research in ASH 2017 Podium Presentations
Roswell Park Cancer Institute's picture
Roswell Park Ca...
12/07/2017 - 14:23
Dr. Mohamad Cherry of Atlantic Hematology Oncology to Lead Meeting Session and Help Present Multiple Studies at Top International Blood Cancer Meeting
Atlantic Health System's picture
Atlantic Health...
12/05/2017 - 09:02
BioLineRx Ltd. Hosts Investor Breakfast Meeting in NY
Biolinerx's picture
Biolinerx
12/04/2017 - 08:21
BioLineRx Reports Overall Survival Results from Long-Term Follow-Up of Phase 2a Trial in r/r AML
Biolinerx's picture
Biolinerx
11/06/2017 - 18:36
FDA Lifts Clinical Hold on Cellectis Phase 1 Clinical Trials with UCART123 in AML and BPDCN
Cellectis's picture
Cellectis
11/02/2017 - 08:36
Preclinical data demonstrate that BL-8040 mobilizes a significant number of these HSCs compared to G-CSF, thus potentially improving graft quality
Biolinerx's picture
Biolinerx
10/10/2017 - 18:36
Hope for Elderly Leukemia Patients
Roswell Park Cancer Institute's picture
Roswell Park Ca...
10/05/2017 - 18:14
A new CRISPR-engineered cancer model to test therapeutics
Broad Institute's picture
Broad Institute
09/26/2017 - 02:27
BioLineRx Announces Initiation of Phase 1b/2 Trial for BL-8040 in AML Under Immunotherapy Collaboration
Biolinerx's picture
Biolinerx
09/14/2017 - 18:14
MD Anderson and Daiichi Sankyo Enter Research Collaboration to Accelerate Development of Acute Myeloid Leukemia Therapies
Daiichi Sankyo's picture
Daiichi Sankyo
09/12/2017 - 22:40
Advancing the Hematology Field
Celgene's picture
Celgene
09/05/2017 - 08:43
MEI Pharma Reports Fiscal Year 2017 Results
MEI Pharma's picture
MEI Pharma
09/04/2017 - 10:17
Cellectis Reports Clinical Hold of UCART123 Studies
Cellectis's picture
Cellectis
09/01/2017 - 12:15
Pfizer Receives FDA Approval for MYLOTARG (gemtuzumab ozogamicin)
Pfizer's picture
Pfizer
09/01/2017 - 09:34
FDA approves Mylotarg for treatment of acute myeloid leukemia
Food and Drug Administration's picture
FDA
09/01/2017 - 02:14
Tracing Blood Cancer Family Tree
Celgene's picture
Celgene
08/07/2017 - 18:14
Fujifilm initiates a Phase I clinical trial of Anti-Cancer Drug FF-10101 in the United States in patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
Fujifilm's picture
Fujifilm
08/03/2017 - 12:05
FDA approves first treatment for certain types of poor-prognosis acute myeloid leukemia
Food and Drug Administration's picture
FDA
08/02/2017 - 05:17
Helsinn Group and MEI Pharma Announce First Patient Dosed in Pivotal Phase 3 Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia
MEI Pharma's picture
MEI Pharma
08/01/2017 - 13:41
FDA approves new targeted treatment for relapsed or refractory acute myeloid leukemia
Food and Drug Administration's picture
FDA
08/01/2017 - 12:42
FDA Grants Approval of IDHIFA, the First Oral Targeted Therapy for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and an IDH2 Mutation
Celgene's picture
Celgene
07/17/2017 - 09:33
ASH Selects 11 Fellows for Research Award to Support Careers in Academic Hematology
American Society of Hematology's picture
American Societ...
07/13/2017 - 06:57
American Society of Hematology Selects 31 Medical Students and Residents for 2017 HONORS Award
American Society of Hematology's picture
American Societ...
07/11/2017 - 17:03
FDA Advisory Committee Votes in Favor of Pfizers MYLOTARG (gemtuzumab ozogamicin) for Acute Myeloid Leukemia
Pfizer's picture
Pfizer
07/04/2017 - 07:10
DFG Approves Seven New Research Units and One New Clinical Research Unit
Deutsche Forschungsgemeinschaft's picture
Deutsche Forsch...
06/30/2017 - 08:27
BESPONSA Approved in the EU for Adult Patients with Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia
Pfizer's picture
Pfizer
06/26/2017 - 21:04
First in Human Administration of UCART123 in Cellectis AML Phase I Clinical Trial at Weill Cornell Medicine, NewYork-Presbyterian Hospital
Cellectis's picture
Cellectis
06/23/2017 - 08:59
NEJM publishes full analysis of Rydapt (midostaurin) Phase III RATIFY trial in newly diagnosed FLT3-mutated acute myeloid leukemia (AML)
Novartis's picture
Novartis
06/21/2017 - 18:06
New Antibody Uses One-Two Punch to Potentially Treat Blood Cancers
American Society of Hematology's picture
American Societ...
06/19/2017 - 12:55
New Markers Found for Acute Myeloid Leukemia
Sapienza University 's picture
SapienzaUniv
06/14/2017 - 07:08
Helsinn Group and MEI Pharma Announce First Patient Dosed in Phase 2 Dose-Optimization Study of Pracinostat and Azacitidine in Myelodysplastic Syndrome
MEI Pharma's picture
MEI Pharma
06/12/2017 - 13:54
Beat AML clinical trial for leukemia is launched
UT Southwestern Medical Center's picture
UTSouthwestern
06/06/2017 - 12:50
Personalizing AML Treatment Through Mutational Profiling
Celgene's picture
Celgene
06/06/2017 - 11:37
Precision Therapy Enasidenib Effective in Treating Deadly Form of Leukemia
American Society of Hematology's picture
American Societ...
06/06/2017 - 10:00
Updated Data from Phase 1 Trial of Oral IDHIFA (enasidenib) Demonstrate Complete Responses and Duration of Response in Patients with Relapsed or Refractory AML and an IDH2 Mutation
Celgene's picture
Celgene
06/05/2017 - 13:35
Four Dana-Farber researchers awarded prestigious 'outstanding investigator awards' by National Cancer Institute
Dana Farber's picture
Dana Farber
06/05/2017 - 05:52
Helsinn Group and MEI Pharma Report Correlation between Mutations in DNA Methylation Pathway and Clinical Response in Phase II Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia
MEI Pharma's picture
MEI Pharma
05/23/2017 - 10:04
Study leads to breakthrough in better understanding acute myeloid leukaemia
University of Birmingham's picture
University of B...
05/22/2017 - 04:58
BioLineRx Announces Regulatory Submission for Phase 1b Trial of BL-8040 in Combination with Atezolizumab in AML
Biolinerx's picture
Biolinerx
05/18/2017 - 08:37
Helsinn Group and MEI Pharma Announce Upcoming Presentations of Gene Mutation and Clinical Response Data from Phase II Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia
MEI Pharma's picture
MEI Pharma
05/03/2017 - 08:58
RYDAPT (midostaurin) Approved for the Treatment of FLT3-Mutated Acute Myeloid Leukemia, available for order at Biologics, Inc.
McKesson's picture
McKesson
04/28/2017 - 14:27
Backed by Dana-Farber research, FDA approves new AML drug
Dana Farber's picture
Dana Farber
04/28/2017 - 07:01
FDA approves new combination treatment for acute myeloid leukemia
Food and Drug Administration's picture
FDA
04/25/2017 - 11:10
New drug compounds could provide non-toxic, effective way to inhibit enzymes that cause cancers
Purdue University's picture
Purdue